Literature DB >> 18791743

Mizoribine for renal sarcoidosis: effective steroid tapering and prevention of recurrence.

Shuichi Ito1, Tomonori Harada, Tomoko Nakamura, Tomoyuki Imagawa, Kiyotaka Nagahama, Takeshi Sasaki, Shuichiro Fujinaga, Yukoh Aihara, Shumpei Yokota.   

Abstract

Sarcoidosis is a systemic disease of unknown etiology that is characterized by chronic non-caseating granulomatous inflammation with tissue destruction. It is an uncommon disease in children, and renal sarcoidosis in particular is very rare in adults and children. A 17-year-old boy with renal sarcoidosis was referred to our hospital with an initial diagnosis of pyelonephritis. Prior treatment with various antibiotics had not been effective, but tentative oral daily prednisolone (PSL) had partially ameliorated his symptoms, although the symptoms recurred during steroid tapering. We detected non-caseating granulomatous interstitial nephritis and numerous sclerotic glomeruli in a second biopsy specimen, compatible with the diagnosis of renal sarcoidosis. The patient was treated with pulsed methyl-prednisolone and oral daily doses of PSL and mizoribine (MZR). During the treatment with MZR, the PSL was successfully tapered, and the patient has since presented no signs of recurrence. Our treatment of this patient shows that treatment with MZR can allow steroid sparing and prevent recurrence in a patient with sarcoidosis.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18791743     DOI: 10.1007/s00467-008-0995-7

Source DB:  PubMed          Journal:  Pediatr Nephrol        ISSN: 0931-041X            Impact factor:   3.714


  21 in total

1.  Clinical pharmacokinetic study of mizoribine in renal transplantation patients.

Authors:  K Sonda; K Takahashi; K Tanabe; S Funchinoue; Y Hayasaka; H Kawaguchi; S Teraoka; H Toma; K Ota
Journal:  Transplant Proc       Date:  1996-12       Impact factor: 1.066

2.  Randomized trial of prolonged chloroquine therapy in advanced pulmonary sarcoidosis.

Authors:  M Baltzan; S Mehta; T H Kirkham; M G Cosio
Journal:  Am J Respir Crit Care Med       Date:  1999-07       Impact factor: 21.405

3.  High-dose mizoribine therapy for childhood-onset frequently relapsing steroid-dependent nephrotic syndrome with cyclosporin nephrotoxicity.

Authors:  Yoshiyuki Ohtomo; Shu-ichiro Fujinaga; Masaru Takada; Hitohiko Murakami; Shunji Akashi; Toshiaki Shimizu; Kazunari Kaneko; Yuichiro Yamashiro
Journal:  Pediatr Nephrol       Date:  2005-08-20       Impact factor: 3.714

4.  Isolated sarcoid granulomatous interstitial nephritis responding to infliximab therapy.

Authors:  Julia Thumfart; Dominik Müller; Birgit Rudolph; Miriam Zimmering; Uwe Querfeld; Dieter Haffner
Journal:  Am J Kidney Dis       Date:  2005-02       Impact factor: 8.860

5.  A multicenter trial of mizoribine compared with placebo in children with frequently relapsing nephrotic syndrome.

Authors:  K Yoshioka; Y Ohashi; T Sakai; H Ito; N Yoshikawa; H Nakamura; T Tanizawa; H Wada; S Maki
Journal:  Kidney Int       Date:  2000-07       Impact factor: 10.612

6.  Isolated sarcoid granulomatous interstitial nephritis: review of five cases at one center.

Authors:  E O'Riordan; R P Willert; R Reeve; P A Kalra; D J O'Donoghue; R N Foley; S Waldek
Journal:  Clin Nephrol       Date:  2001-04       Impact factor: 0.975

7.  [Neurosarcoidosis treated with mycophenolate mofetil: two cases].

Authors:  A Chaussenot; V Bourg; S Chanalet; J M Fornari; C Lebrun
Journal:  Rev Neurol (Paris)       Date:  2007-04       Impact factor: 2.607

8.  Successful tumor necrosis factor alpha blockade treatment in therapy-resistant sarcoidosis.

Authors:  Kai U Ulbricht; Matthias Stoll; Janine Bierwirth; Torsten Witte; Reinhold E Schmidt
Journal:  Arthritis Rheum       Date:  2003-12

9.  Mizoribine oral pulse therapy for patients with disease flare of lupus nephritis.

Authors:  H Tanaka; K Suzuki; T Nakahata; K Tsugawa; E Ito; S Waga
Journal:  Clin Nephrol       Date:  2003-12       Impact factor: 0.975

10.  The kidney in sarcoidosis.

Authors:  F J Casella; M Allon
Journal:  J Am Soc Nephrol       Date:  1993-03       Impact factor: 10.121

View more
  1 in total

Review 1.  Non-infectious pediatric uveitis: an update on immunomodulatory management.

Authors:  Srilakshmi M Sharma; Andrew D Dick; Athimalaipet V Ramanan
Journal:  Paediatr Drugs       Date:  2009       Impact factor: 3.022

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.